Cargando…

Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells

The CRISPR/Cas9 system is a versatile tool for functional genomics and forward genetic screens in mammalian cells. However, it has been challenging to deliver the CRISPR components to sensitive cell types, such as primary human hematopoietic stem and progenitor cells (HSPCs), partly due to lentivira...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yudovich, David, Bäckström, Alexandra, Schmiderer, Ludwig, Žemaitis, Kristijonas, Subramaniam, Agatheeswaran, Larsson, Jonas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769964/ https://www.ncbi.nlm.nih.gov/pubmed/33372184 http://dx.doi.org/10.1038/s41598-020-79724-x

Ejemplares similares

Combinatorial gene targeting in primary human hematopoietic stem and progenitor cells
por: Bäckström, Alexandra, et al.
Publicado: (2022)

Efficient and nontoxic biomolecule delivery to primary human hematopoietic stem cells using nanostraws
por: Schmiderer, Ludwig, et al.
Publicado: (2020)

Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations
por: Subramaniam, Agatheeswaran, et al.
Publicado: (2022)

Site-specific CRISPR-based mitochondrial DNA manipulation is limited by gRNA import
por: Schmiderer, Ludwig, et al.
Publicado: (2022)

The stem cell–supporting small molecule UM171 triggers Cul3-KBTBD4–mediated degradation of ELM2 domain–harboring proteins
por: Žemaitis, Kristijonas, et al.
Publicado: (2023)

Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives
por: Dong, Wendy, et al.
Publicado: (2021)

Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells
por: Cromer, M. Kyle, et al.
Publicado: (2022)

Transient inhibition of NF-κB signaling enhances ex vivo propagation of human hematopoietic stem cells
por: Talkhoncheh, Mehrnaz Safaee, et al.
Publicado: (2018)

Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration
por: Bloomer, Hanan, et al.
Publicado: (2021)

S255: CELLULAR SENESCENCE AND INFLAMMATORY PROGRAMS ARE UNINTENDED CONSEQUENCES OF CRISPR-CAS9 GENE EDITING IN HEMATOPOIETIC STEM AND PROGENITOR CELLS
por: Conti, Anastasia, et al.
Publicado: (2023)

Engineered human Diamond-Blackfan anemia disease model confirms therapeutic effects of clinically applicable lentiviral vector at single-cell resolution
por: Liu, Yang, et al.
Publicado: (2023)

Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing
por: Ortinski, Pavel I., et al.
Publicado: (2017)

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
por: Wilbie, Danny, et al.
Publicado: (2019)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
por: Heckl, Dirk, et al.
Publicado: (2014)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich’s Ataxia
por: Rocca, Celine J., et al.
Publicado: (2020)

Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells
por: Zhao, Guannan, et al.
Publicado: (2017)

Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
por: Brunetti, Lorenzo, et al.
Publicado: (2018)

Efficient CRISPR/Cas9-Mediated Gene Knockin in Mouse Hematopoietic Stem and Progenitor Cells
por: Tran, Ngoc Tung, et al.
Publicado: (2019)

Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing
por: Kim, Dongyoon, et al.
Publicado: (2020)

Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells
por: Huo, Wenying, et al.
Publicado: (2017)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Functional profiling of single CRISPR/Cas9-edited human long-term hematopoietic stem cells
por: Wagenblast, Elvin, et al.
Publicado: (2019)

DNA Methylation and Histone Modifications Are the Molecular Lock in Lentivirally Transduced Hematopoietic Progenitor Cells
por: Ngai, Siew Ching, et al.
Publicado: (2015)

Staurosporine Increases Lentiviral Vector Transduction Efficiency of Human Hematopoietic Stem and Progenitor Cells
por: Lewis, Gretchen, et al.
Publicado: (2018)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Genome Editing in Bacteria: CRISPR-Cas and Beyond
por: Arroyo-Olarte, Ruben D., et al.
Publicado: (2021)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells
por: Holmgaard, Andreas, et al.
Publicado: (2017)

High Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome Editing
por: Sürün, Duran, et al.
Publicado: (2017)

Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
por: Bak, Rasmus O, et al.
Publicado: (2017)

Protocol for Efficient CRISPR/Cas9/AAV-Mediated Homologous Recombination in Mouse Hematopoietic Stem and Progenitor Cells
por: Tran, Ngoc Tung, et al.
Publicado: (2020)

Genetic barcodes allow traceability of CRISPR/Cas9-derived Aspergillus niger strains without affecting their fitness
por: Garrigues, Sandra, et al.
Publicado: (2021)

Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector
por: Kabadi, Ami M., et al.
Publicado: (2014)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

The Rise of CRISPR/Cas for Genome Editing in Stem Cells
por: Shui, Bing, et al.
Publicado: (2016)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

Multiplex genome editing of microorganisms using CRISPR-Cas
por: Adiego-Pérez, Belén, et al.
Publicado: (2019)

CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kdjc73acj8nlqmbhs57tm8humd